1. Breitbach, G. P., Villena, C., Schwickerath, J., Kunz, T., Hurst, U., Schmidt-Rhode, P., Friedrich, E. J., Artmeyer, E., Schröder, M., Eberl, M., Franck, J., Meinen, K., Schiller, S., Wernicke, K., Sasse, G., Schmid, H. & Bastert, G. (1994). Treosulfan bei fortgeschrittenem Ovarialcarcinom: eine Phase III-studie. Arch Gynecol Obstet 225(suppl.1): 80–80.
2. Carmichael, J., De Graff, W. G., Gazdar, A. F., Minna, J. D. & Mitchell, J. B. (1987). Evaluation of a tetrazolium based semi-automated colorimetric assay. I. Assessment of chemosensitivity testing. Cancer Res 47: 936–940.
3. Feit, P. W. (1961). Stereoisomere 1,4-di-O-methanesulfonyl-butan-2,3,4,4-tetrole. Tetrahedron Lett 20: 716–717.
4. Feit, P. W. (1964). 1,4-Bismethanesulfonates of the steroisomeric butane tetrads and related compounds. J Med Chem 7: 14–17.
5. Feit, P. W., Rastrup-Andersen, N. & Matagne, R. (1970). Studies on epoxide formation from (2S,3S)-threitol 1,4-bismethanesulfonate. The preparation and biological activity of (2S,3S)-1,2-epoxy-3-4-butanediol 4-methanesulfonate. J Med Chem 13: 1173–1175.